Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists

Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists

US Patent 10653650 · Granted May 19, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of diseases by concurrently eliciting remyelination effects and immuno2025
Treatment of diseases by concurrently eliciting remyelination effects and immuno2025
Treatment of diseases by concurrently eliciting remyelination effects and immuno2025
Treatment of diseases by concurrently eliciting remyelination effects and immuno2025
Treatment of diseases by concurrently eliciting remyelination effects and immuno2025
Combination therapy for the treatment of migraines2025
RXR agonist salt form, polymorphs thereof, and uses thereof2025
VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergi2024
VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergi2024
Methods of using RARγ agonists for cancer treatment2024
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders2024
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders2024